Atg7 in CD4 + T cells improves intestinal mucosal inflammation by regulating Ets1‐mediated T cell differentiation
Clinical and Translational Medicine · 2025-09 · 15 (9)
DOI: 10.1002/ctm2.70462 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Medicine, online erschienen am 31.08.2025. Verfasst von Yue-Tao Zhou und 15 weiteren Autor:innen. Beteiligte Einrichtung: MOE Medical Basic Research Innovation Center for Gut Microbiota and Chronic Diseases, Wuxi School of Medicine, Jiangnan University, Wuxi, People's Re…. Hauptthemen laut MEDLINE: CD4-Positive T-Lymphocytes, Cell Differentiation, Intestinal Mucosa, Autophagy-Related Protein 7. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Jiangsu Natural Science Foundation of China, Postdoctoral Science Foundation of Jiangsu.
Abstract (Originalsprache)
Background
Atg7‐autophagy–related gene 7 contributes as an immune cell function regulator, particularly involved in CD4⁺ T cell response. Nevertheless, the specific contribution of Atg7 in CD4⁺ T cells sensitive immune responses in inflammatory bowel disease (IBD) remains largely unclear. This study explores the functional significance and regulatory mechanisms of CD4⁺ T cell‐specific Atg7 in IBD.
Methods
Real‐Time Quantitative Reverse Transcription PCR (qRT‐PCR), western blotting analysis, flow cytometry and immunohistochemistry were employed to evaluate ATG7 expression in peripheral blood and colonic mucosal biopsies from IBD patients. Peripheral CD4⁺ T cells were transfected with lentivirus vectors encoding either ATG7 (LV‐ ATG7 ) or ATG7 short hairpin RNA (LV‐sh ATG7 ). Furthermore, mice with a CD4⁺ T cell conditional knockout of Atg7 ( Atg7 ΔCD4 ) were generated, and CD4 + T cells of splenic origin were subjected to RNA‐seq.
Results
ATG7 level was markedly elevated in inflamed mucosa tissues and peripheral blood CD4 + T cells of patients with active Crohn's disease compared to healthy individuals. Overexpression of ATG7 suppressed Th1 differentiation while enhancing the induction of iTreg cells. Atg7 ΔCD4 mice exhibited exacerbated result of 2,4,6‐trinitrobenzenesulphonic acid‐induced experimental colitis, as did Rag1 −/− mice adoptively transferred with CD45 RBhigh CD4 + T cells from Atg7 ΔCD4 donors. RNA‐seq analysis revealed that E26 transformation‐specific sequence‐1 ( Ets1 ) acts downstream of Atg7 and mediates its regulatory effects on Th1 and Treg cell differentiation.
Conclusion
Our data indicate that Atg7 alleviates mucosal inflammation by modulating Th1/Treg differentiation through the regulation of Ets1 expression. Thus, CD4⁺ T cell‐expressed Atg7 may serve as a promising therapeutic approach for IBD. Key points Atg7 expression was significantly elevated in the inflamed mucosa and blood CD4 + T cells of patients with active Crohn's disease. Specific‐knockout of Atg7 in CD4 + T cells leads to exacerbated colitis severity. Ets1 functions as a target of Atg7, where it inhibits Th1 cell differentiation and promotes Treg cell differentiation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MOE Medical Basic Research Innovation Center for Gut Microbiota and Chronic Diseases, Wuxi School of Medicine, Jiangnan University, Wuxi, People's Republic of China.
- Wuxi School of Medicine, Jiangnan University, Wuxi, People's Republic of China.
- Laboratory Animal Center, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
- Department of Nursing, Shanghai Seventh People's Hospital, Shanghai, People's Republic of China.
- Department ofGastroenterology, Nanjing Medical University Affiliated Wuxi Second Hospital, Wuxi, People's Republic of China.
- Department of Gastroenterology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, People's Republic of China.
ORCID-Profile: Yue-Tao Zhou, Hong Chen
Förderung
- National Natural Science Foundation of China
- Jiangsu Natural Science Foundation of China
- Postdoctoral Science Foundation of Jiangsu
- Wuxi Science and Technology Development Fund
- Light of Taihu Lake
- Science and Technology Bureau of Wuxi City
- Top Talent Support Program for young and middle-aged people of Wuxi Health Committee
Zitieren
APA
Zhou, Y. T., Zhang, Q. G., Du, S. Y., Chen, H., Zhu, M. Z., Ai, M., Li, S. S., Dai, M. N., Wang, X. T., Jin, Y., Zhu, Y. W., Lu, J., Xu, F., Zhu, X. X., Qiu, L. Y., & Sun, H. J. (2025). Atg7 in CD4 + T cells improves intestinal mucosal inflammation by regulating Ets1‐mediated T cell differentiation. Clinical and Translational Medicine, 15(9). https://doi.org/10.1002/ctm2.70462
Vancouver
Zhou YT, Zhang QG, Du SY, Chen H, Zhu MZ, Ai M, et al. Atg7 in CD4 + T cells improves intestinal mucosal inflammation by regulating Ets1‐mediated T cell differentiation. Clinical and Translational Medicine. 2025;15(9). doi:10.1002/ctm2.70462
BibTeX
@article{Zhou2025,
author = {Zhou, Yue-Tao and Zhang, Quan-Gui and Du, Si-Yuan and Chen, Hong and Zhu, Mei-Zhen and Ai, Min and Li, Shuang-Shuang and Dai, Meng-Nan and Wang, Xi-Ting and Jin, Yan and Zhu, Ying-Wei and Lu, Jian and Xu, Fei and Zhu, Xue-Xue and Qiu, Li-Ying and Sun, Hai-Jian},
title = {Atg7 in CD4 + T cells improves intestinal mucosal inflammation by regulating Ets1‐mediated T cell differentiation},
journal = {Clinical and Translational Medicine},
year = {2025},
volume = {15},
number = {9},
doi = {10.1002/ctm2.70462}
}
EUVIMED